Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

Microsoft security researchers have discovered a new backdoor malware that uses the OpenAI Assistants API as a covert command ...

OpenAI CEO Sam Altman is reportedly launching Merge Labs, a new brain-computer interface startup, with biomolecular engineer ...

In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...

Digits announced the release of Digits API which allows computers to connect directly with the company's Autonomous General Ledger system without needing custom integrations.

Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...

Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...

Synchron was spun out of University of Melbourne by cofounders Dr Tom Oxley, Prof Nicholas Opie, and Dr Rahul Sharma in 2012.